RAPAFLO
RAPAFLO
Discontinued
DIN Number
02361671
Drug Class
Human
Market Date
Oct 26, 2011
Company
HC
Allergan, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02361671
AIG Number0152869002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04CA04 SILODOSIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification12:16.04.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
SILODOSINActive
Strength: 8 MG
Monograph: SILODOSIN